New Enterprise Associates 14, L.P.'s Net Worth

$159 Million

Who is New Enterprise Associates 14, L.P.?

New Enterprise Associates 14, L.P. has an estimated net worth of $159 Million. This is based on reported shares across multiple companies, which include MULESOFT, INC, Oyster Point Pharma, Inc., APPIAN CORP, Mersana Therapeutics, Inc., Adaptimmune Therapeutics PLC, Loxo Oncology, Inc., CHAMPIONS ONCOLOGY, INC., Surface Oncology, Inc., Galera Therapeutics, Inc., Tracon Pharmaceuticals, Inc., Mirna Therapeutics, Inc., Cerecor Inc., IMARA Inc., Casper Sleep Inc., ZeroFox Holdings, Inc., Strongbridge Biopharma plc, and INTERLEUKIN GENETICS INC.

SEC CIK

New Enterprise Associates 14, L.P.'s CIK is 0001544328

Past Insider Trading and Trends

2018 was New Enterprise Associates 14, L.P.'s most active year for acquiring shares with 13 total transactions. New Enterprise Associates 14, L.P.'s most active month to acquire stocks was the month of February. 2022 was New Enterprise Associates 14, L.P.'s most active year for disposing of shares, totalling 19 transactions. New Enterprise Associates 14, L.P.'s most active month to dispose stocks was the month of December. 2017 saw New Enterprise Associates 14, L.P. paying a total of $24,009,000.00 for 58,948,211 shares, this is the most they've acquired in one year. In 2017 New Enterprise Associates 14, L.P. cashed out on 70,082,988 shares for a total of $66,073,750.64, their largest year based on trade value.